Areeba Hussain

Areeba is working as a medical and healthcare writer for the last five years. She graduated in Medical Microbiology and Immunology and worked as a junior scientist in Cancer Metabolism Labs. She regularly posts content related to medicine, disease management, therapeutic technology, awareness, alternative healing, and reviews.

Research Proves Intermittent Fasting to Increase Life Expectancy

Scientists claimed that intermittent fasting has many health benefits. They reviewed the already existing evidence on the intermittent fasting diet that restricts the time of eating. A Johns Hopkins Medicine neuroscientist, Mark Mattson adopted an intermittent fasting diet for himself 20 years ago, and his fellows reviewed studies involving humans and animals. Intermittent fasting includes prolonged periods in which…

Read More

Is It Possible To Make Blood Cells On Demand- Medical Research Explains How

Reconstitution of human blood carries extreme importance in medical and health sciences as it may completely change the therapeutics for certain chronic diseases i.e. blood cancer and anemia. But to make this happen, transplantation of blood and hematopoietic stem cells (HSCs)’s engraftment is required. After this, it is possible to create different blood cell types…

Read More

“KNOW Bio” Acquires “Clinical Sensors” To Advance Diabetes Management Through Advanced Technology 

KNOW Bio is a North Carolina based company that has acquired a new nitric oxide-based medical technology. Along with some other companies working in biotechnology, KNOW Bio is trying to make reforms by technological interventions, especially for diabetes. Today Know Bio announced its acquisition Clinical Sensors Inc and renamed it as Diabetic Health Inc. (DHI)….

Read More

Safe and Effective Treatment for Elderly AF Patients for Routine Clinical Practice

Different study reports and large real-world data reinforce the safety and effectiveness of LIXIANA (edoxaban) in elderly atrial fibrillation (AF) patients with comorbidities in routine clinical use. Munich, Bavaria, Germany – Daiichi Sankyo Europe GmbH, the pharmaceutical company has shared the results of an observational study on the effects of LIXIANA (edoxaban) in Caucasian atrial fibrillation…

Read More

Introducing An Affordable Health System Initiative by Alzheimer’s Association For Dementia Patients

A new low price Health System Initiative is launched today by Alzheimer’s Association for people suffering from dementia. Efforts are being done to facilitate health systems improving outcomes and manage expenses for dementia patients. This association is focused on providing and increasing dementia care in the area of clinical practice. The association is aimed to…

Read More

 Agendia Is Working On Two New Genomic Profiling Tests For Patients Of Early-Stage Breast Cancer

The new data related to early-stage breast cancer has been released and presented at San Antonio Breast Cancer Symposium (SABCS). This data shows that a woman doesn’t need any other way like chemotherapy because of the test  MammaPrint 70-gene assay is more effective and useful. This announced data has been compared with the genomic profiling…

Read More

Prescient Medicine To Collaborate With Erasmus For Studying Opioid Addiction in Netherlands

Prescient Medicine holding Inc has collaborated with the department of clinical chemistry, Erasmus MC (CC-EMC) to study the risks of opioid addiction in the Netherlands. The announcement was made today. This new partnership will be centered on Prescient Medicine’s novel genetic testing technology that is designed to accurately assess the risks of opioid addiction before…

Read More